Literature DB >> 15545275

Early growth response-1 regulates lipopolysaccharide-induced suppressor of cytokine signaling-1 transcription.

Justin Mostecki1, Brian M Showalter, Paul B Rothman.   

Abstract

Suppressor of cytokine signaling (SOCS)-1 is a critical regulator of lipopolysaccharide (LPS) tolerance and LPS-induced cytokine production. The mechanisms regulating the transcription of SOCS-1 in response to LPS are not entirely understood. Functional analysis of the SOCS-1 promoter demonstrates that early growth response-1 (Egr-1) is an important transcriptional regulator of SOCS-1. Two Egr-1 binding sites are present within the SOCS-1 promoter as shown by EMSA and supershift analysis. Further, mutation of the Egr-1 binding sites significantly reduces both the basal and LPS-induced transcriptional activity of the promoter. Chromatin immunoprecipitation experiments confirm LPS-induced binding of Egr-1 to the SOCS-1 promoter in vivo. Additionally, Egr-1(-/-) macrophages show reduced levels of LPS-induced SOCS-1 expression in comparison with macrophages derived from Egr-1(+/+) littermate controls. These results demonstrate an important role for Egr-1 in regulating both the basal and LPS-induced activity of the SOCS-1 promoter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545275     DOI: 10.1074/jbc.M408938200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Cell invasion and strain dependent induction of suppressor of cytokine signaling-1 by Toxoplasma gondii.

Authors:  Andrea Stutz; Henning Kessler; Mariel-Esther Kaschel; Markus Meissner; Alexander H Dalpke
Journal:  Immunobiology       Date:  2011-08-27       Impact factor: 3.144

Review 2.  SOCS1 and its Potential Clinical Role in Tumor.

Authors:  Jie Ying; Xiaoyan Qiu; Yu Lu; Miaomiao Zhang
Journal:  Pathol Oncol Res       Date:  2019-02-13       Impact factor: 3.201

3.  Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT.

Authors:  Akihiro Kimura; Tetsuji Naka; Tatsushi Muta; Osamu Takeuchi; Shizuo Akira; Ichiro Kawase; Tadamitsu Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-15       Impact factor: 11.205

4.  A SOCS-1 promoter variant is associated with total serum IgE levels.

Authors:  Justin Mostecki; Suzanne L Cassel; Walter T Klimecki; Debra A Stern; Judit Knisz; Sachiyo Iwashita; Penelope Graves; Rachel L Miller; Maartje van Peer; Marilyn Halonen; Fernando D Martinez; Donata Vercelli; Paul B Rothman
Journal:  J Immunol       Date:  2011-07-27       Impact factor: 5.422

5.  Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-kappaB-dependent induction of SOCS1.

Authors:  Soratree Charoenthongtrakul; Qinjie Zhou; Noula Shembade; Nicole S Harhaj; Edward W Harhaj
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

6.  An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism.

Authors:  Ning Shen; Xiao Yu; Fei-Yan Pan; Xiang Gao; Bin Xue; Chao-Jun Li
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

7.  SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases.

Authors:  Minoru Fujimoto; Tetsuji Naka
Journal:  Gastroenterol Res Pract       Date:  2010-09-02       Impact factor: 2.260

8.  Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics.

Authors:  Stephen A Ramsey; Sandy L Klemm; Daniel E Zak; Kathleen A Kennedy; Vesteinn Thorsson; Bin Li; Mark Gilchrist; Elizabeth S Gold; Carrie D Johnson; Vladimir Litvak; Garnet Navarro; Jared C Roach; Carrie M Rosenberger; Alistair G Rust; Natalya Yudkovsky; Alan Aderem; Ilya Shmulevich
Journal:  PLoS Comput Biol       Date:  2008-03-21       Impact factor: 4.475

9.  SOCS1 is a negative regulator of metabolic reprogramming during sepsis.

Authors:  Annie Rocio Piñeros Alvarez; Nicole Glosson-Byers; Stephanie Brandt; Soujuan Wang; Hector Wong; Sarah Sturgeon; Brian Paul McCarthy; Paul R Territo; Jose Carlos Alves-Filho; C Henrique Serezani
Journal:  JCI Insight       Date:  2017-07-06

10.  Effects of Lansoprazole on the Lipopolysaccharide-Stimulated Toll-Like Receptor 4 Signal Transduction Systems: A Study Using the 293hTLR4/MD2-CD14 Cells.

Authors:  Tadashi Ohara; Yuhsaku Kanoh; Keiichi Yoshino; Masaki Kitajima
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.